Medicare Enrolled

Dr. Laura Rodgers, NP

Acute Care Nurse Practitioner · Center, TX
Low-engagement
630 HURST ST, Center, TX 75935
9366571944
In practice since 2013 (12 years)
NPI: 1043659717 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rodgers from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodgers? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rodgers

Dr. Laura Rodgers is an acute care nurse practitioner in Center, TX, with 12 years of NPI registration.

Between the years covered by Open Payments, Dr. Rodgers received a total of $5,032 from 31 pharmaceutical and/or device companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in acute care nurse practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rodgers is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice $5,032 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,032
Total received (2021-2024)
Avg $1,258/year across 4 years
Top 5% in TX for acute care nurse practitioner
31
Companies
300
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,796 (95.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$236 (4.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,225
2023
$1,460
2022
$754
2021
$1,593

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$682
Boehringer Ingelheim Pharmaceuticals, Inc.
$625
Lilly USA, LLC
$566
Novo Nordisk Inc
$532
PFIZER INC.
$523
ABBVIE INC.
$389
AbbVie Inc.
$290
Astellas Pharma US Inc
$236
Bayer Healthcare Pharmaceuticals Inc.
$203
Amgen Inc.
$199
Otsuka America Pharmaceutical, Inc.
$149
GlaxoSmithKline, LLC.
$88
ITI, Inc.
$82
IDORSIA PHARMACEUTICALS US INC
$68
Bayer HealthCare Pharmaceuticals Inc.
$60
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$51
Antares Pharma, Inc.
$43
Merck Sharp & Dohme Corporation
$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$25
Dexcom, Inc.
$25
Allergan, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$21
Axsome Therapeutics, Inc.
$17
Enterra Medical, Inc.
$17
Biohaven Pharmaceuticals, Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Mylan Specialty L.P.
$15
Alkermes, Inc.
$15
Almatica Pharma LLC
$13
OptiNose US, Inc.
$13
Genentech USA, Inc.
$4
Top 3 companies account for 37.2% of total payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO ELLIPTA · Aimovig · Austedo XR · Auvelity · BELSOMRA · BREZTRI · CAPLYTA · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · FARXIGA · FASENRA · GRALISE · JANUVIA · JARDIANCE · Kerendia · LYBALVI · LifeVest · MOUNJARO · NOCDURNA · NURTEC ODT · OFEV · Otezla · Ozempic · PREMARIN · PREVNAR 13 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYNJARDY · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VRAYLAR · Veozah · Wegovy · XIFAXAN · XYOSTED · Xhance · Xofluza · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for acute care nurse practitioner in TX.

Looking for an acute care nurse practitioner in Center?
Compare acute care nurse practitioners in the Center area by procedure volume, costs, and industry payment transparency.
Browse acute care nurse practitioners nearby

Geographic Context

Acute care nurse practitioners within 10 mi
1
Per 100K population
4.1
County median income
$50,436
Nearest hospital
CHI ST LUKES HEALTH MEMORIAL SAN AUGUSTINE
15.7 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rodgers is an acute care nurse practitioner, with low-engagement industry engagement in the top 5% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Rodgers receive payments from pharmaceutical companies?
Yes. Dr. Rodgers received a total of $5,032 from 31 companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Rodgers) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Acute Care Nurse Practitioners in Center
Browse acute care nurse practitioners in Center ranked by procedure volume and transparency data.
Highest volume
Top Acute Care Nurse Practitioners in TX
Acute care nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Acute Care Nurse Practitioners in TX
Which TX acute care nurse practitioners receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →